newsfilter
← Latest News
GlobeNewswire·

Wave Life Sciences to Present at Jefferies Global Healthcare Conference in London

  • Wave Life Sciences (Nasdaq: WVE) announced that CEO Paul Bolno will participate in an analyst-led fireside chat at the Jefferies Global Healthcare Conference in London on Wednesday, November 18, 2026.
  • The presentation is scheduled for 3:30 p.m. GMT / 10:30 a.m. ET.
  • A live webcast of the event will be accessible via the "Investor Events" section of the company's website, with a replay archived for a limited time post-event.
  • Wave utilizes its PRISM platform, which combines RNAi (SpiNA) & RNA editing (AIMers) modalities to address rare & common disorders.
  • The company's lead pipeline programs include obesity (WVE-007), alpha-1 antitrypsin deficiency (WVE-006), & PNPLA3 I148M liver disease (WVE-008).
  • Wave Life Sciences is headquartered in Cambridge, MA.
Company
Wave Life Sciences USA, Inc.
Keywords
Nasdaq:WVE, Wave Life Sciences USA, Inc.